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INTRODUCTION
Atypical ductal hyperplasia (ADH) of the breast is associat-
ed with a 4- to 5-fold increased risk of malignancy. Owing to 
this increased risk, an ADH diagnosis is typically an indication 
for surgical excision [1]. ADH usually manifests as microcalci-
fications on mammograms, and it has been diagnosed via ste-
reotactic vacuum-assisted breast biopsy (VABB). If suspicious 
microcalcifications are diagnosed as ADH via VABB, prompt 
surgery is necessary because of the potential to upgrade to 
malignancy. The upgrade rate to invasive cancer or ductal car-
cinoma in situ (DCIS) in the literature varies from 11.5% to 
62% [2-5]. This range is influenced by either imaging features 
(i.e., presence of calcifications rather than masses) or needle 
size [6-9].
VABB is an accurate and useful method for diagnosing 
mammographically detected lesions including suspicious mi-
crocalcifications [6,10,11]. Compared to 14-gauge core needle 
biopsy (CNB), VABB has an advantage of lower underestima-
tion rate because of the larger amount of calcification retrieval. 
Therefore, VABB is preferred for biopsy of suspicious micro-
calcifications on mammograms [1]. Occasionally, microcalcifi-
cations can be completely extracted during the procedure, and 
whether further excision is necessary is debatable, particularly 
in cases where residual calcifications are absent [1,8,12-14].
The purpose of our study was to evaluate the underestima-
tion rate of ADH on VABB, and to examine the correlation be-
tween residual microcalcifications and the underestimation 
rate of ADH.
Absence of Residual Microcalcifications in Atypical Ductal Hyperplasia 
Diagnosed via Stereotactic Vacuum-Assisted Breast Biopsy: Is Surgical 
Excision Obviated?
Inyoung Youn, Min Jung Kim1, Hee Jung Moon1, Eun-Kyung Kim1
Department of Radiology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul; 1Department of Radiology, Research Institute 
of Radiological Science, Yonsei University College of Medicine, Seoul, Korea
ORIGINAL ARTICLE
J Breast Cancer 2014 September; 17(3): 265-269 http://dx.doi.org/10.4048/jbc.2014.17.3.265
Purpose: The purpose of our study was to evaluate the under­
estimation rate of atypical ductal hyperplasia (ADH) on vacuum­
assisted breast biopsy (VABB), and to examine the correlation 
between residual microcalcifications and the underestimation 
rate of ADH. Methods: A retrospective study was performed on 
27 women (mean age, 49.2±9.2 years) who underwent addi­
tional excision for ADH via VABB for microcalcifications ob­
served by using mammography. The mammographic findings, 
histopathologic diagnosis of all VABB and surgical specimens, 
and association of malignancy with residual microcalcifications 
were evaluated. The underestimation rate of ADH was also cal­
culated. Results: Of the 27 women with microcalcifications, nine 
were upgraded to ductal carcinoma in situ (DCIS); thus, the un­
derestimation rate was 33.3% (9/27). There was no difference in 
age (p=0.40) and extent of microcalcifications (p=0.10) when 
comparing benign and malignant cases. Six of 17 patients 
(35.3%) with remaining calcifications after VABB were upgraded 
to DCIS, and three of 10 patients (30%) with no residual calcifi­
cations after VABB were upgraded (p=1.00). Conclusion: The 
underestimation rate of ADH on VABB was 33.3%. Furthermore, 
30% of patients with no remaining calcifications were upgraded 
to DCIS. Therefore, we conclude that all ADH cases diagnosed 
via VABB should be excised regardless of the presence of resid­
ual microcalcifications.
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METHODS 
Between June 2008 and January 2013, 570 cases of 528 pa-
tients in our institution underwent VABB for the presence of 
microcalcifications on mammograms. Thirty-five of these pa-
tients were diagnosed with ADH (6.6%, 35/528). Of the 35 
ADH cases, additional excision was not performed in eight pa-
tients (7, owing to follow-up loss; 1, owing to treatment with 
chemotherapy for contralateral breast cancer), all of whom 
were categorized as 4A (low suspicion of malignancy) of Breast 
Imaging-Reporting and Data System (BI-RADS). The remain-
ing 27 patients who underwent additional surgery (49.2± 9.2 
years; age range, 31–68 years; median age, 49 years) were en-
rolled in this retrospective study. The Institutional Review 
Board approved this retrospective study, and informed consent 
was waived for the review of images and records (Ethics Com-
mittee reference number: 2013-0799-001).
In all included cases, standard mediolateral oblique views, 
craniocaudal views, and additional magnification views were 
obtained with dedicated equipment (Senographe DS, GE 
Medical Systems, Milwaukee, USA; Lorad Selenia, Hologic, 
Danbury, USA) before VABB. We performed additional breast 
ultrasonography for lesion localization, but there was no evi-
dence of sonographic abnormalities that correlated with mi-
crocalcifications. For the biopsy, the patients lay on a stereotac-
tic VABB table (Digital Stereotaxy with Senographe DS Inter-
ventional; GE Medical Systems) in the lateral decubitus posi-
tion with the breast lesion side up. Digital scout images and 
15° paired stereotactic images were obtained to localize the 
microcalcifications. A short skin incision was made using local 
anesthesia under aseptic conditions. The lesion was localized, 
and the VABB device (Mammotome; Biopsys/Ethicon Endo-
Surgery, Cincinnati, USA) was inserted into the appropriate 
depth by using a single 8- or 11-gauge needle with gauge size 
determined on a case-by-case basis. A localizing clip (Micro-
Mark; Biopsys/Ethicon Endo-Surgery) was placed at the site of 
biopsy, and specimen mammography was performed to con-
firm calcification retrieval. A follow-up unilateral mammogra-
phy or magnification view was also performed to evaluate re-
sidual microcalcifications and the location of the clip. After 
VABB, all patients underwent additional surgery by using the 
mammography-guided wire-localization technique. Specimen 
mammography was also performed to check including clip 
and residual microcalcifications after surgery.
Prebiopsy and postbiopsy mammograms were reviewed 
retrospectively by a breast radiologist (I.Y.). All mammograms 
were interpreted according to the BI-RADS lexicon, and the 
morphological features of microcalcifications (shape, distribu-
tion, numbers, and extent) were evaluated with a final category 
assessment to determine the characteristics of the lesions. The 
extent of all microcalcifications was expressed as mean± SD 
(mm). We also evaluated whether residual microcalcifications 
were present after the procedure. 
We calculated the underestimation rate of ADH, which was 
defined as the percentage of surgically proven malignant cases 
among the ADH cases diagnosed via VABB. Furthermore, in 
lesions of the same BI-RADS category, we analyzed the rate of 
ADH underestimation between the patients with and without 
microcalcifications after VABB. We further divided the data 
based on the needle type (8- or 11-gauge) and calculated the 
underestimation rate in each group.
The histopathological diagnosis of all VABB and surgical 
specimens was retrospectively recorded through a pathological 
report. Categorical data were summarized as frequencies and 
percentages. We used the two-sample t-test to compare pa-
tients with benign or malignancy according to the age and ex-
tent of their microcalcifications. We also evaluated the associ-
ation of malignancy with existing residual microcalcifications 
by using the Fisher exact test. All statistical analyses were per-
formed by using statistical software (SPSS for Windows, ver-
sion 20.0; IBM Corp., Armonk, USA). Statistical significance 
was established considering a p-value of less than 0.05.
RESULTS
Among the 27 ADH patients enrolled in this study (49.2±
9.2 years), nine women (51.9 ± 10.0 years) were diagnosed 
with malignancy after surgery; therefore, the underestimation 
rate was 33.3% (9/27). All malignancies were DCIS. A subse-
quent unilateral mammography or magnification view after 
VABB was performed (mean duration time, 15 ± 11 days; 
range, 6–46 days); the characteristics of microcalcifications 
with final category assessments in the benign and malignant 
groups are presented in Table 1. There was no significant dif-
ference in the extent of microcalcifications when comparing 
the benign and malignant groups (p= 0.10; benign, 11.3± 9.7 
mm; malignant, 16.7± 16.4 mm; total, 13.1± 12.3 mm). Re-
garding the shape, the majority of calcifications were com-
posed of amorphous (n= 11) or coarse (n= 4) calcifications in 
the benign group, and amorphous (n= 3), fine pleomorphic 
(n= 2), or linear branching (n= 2) calcifications in the malig-
nant group. Regarding distribution, the number of clustered 
microcalcifications was the highest in both the benign (n= 15) 
and malignant (n = 5) groups. BI-RADS category 4C cases 
were observed only in the malignant group (n= 3). Table 2 
summarizes the comparison of pathologic results of VABB 
and surgical excision. Although there was no significant dif-
ference with regard to the needle size (p= 0.22), the underesti-
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malignant groups are presented in Table 3. On the basis of the 
results on mammograms after VABB, three patients (30%) 
were upgraded to DCIS among the patients without residual 
microcalcifications (Figure 1), whereas six of 17 patients with 
remaining microcalcifications (35.3%) were upgraded to DCIS 
(p= 1.00) (Figure 2). Of the three patients with underestima-
tion and in whom no remaining microcalcifications were ob-
served on the mammogram after VABB, an 11-gauge needle 
was used in two patients and an 8-gauge needle in one patient. 
Table 1. Comparison of excisional biopsy results of atypical ductal 






Age (yr)* 47.9±8.7 51.9±10.0 0.40
Microcalcifications on 
   mammography
   Extent (mm)* 11.3±9.7 16.7±16.4 0.10
   Shape
     Round 1 (5.6) 1 (11.1)
     Amorphous 11 (61.1) 3 (33.3)
     Coarse heterogenous 4 (22.2) 1 (11.1)
     Fine pleomorphic 2 (11.1) 2 (22.2)
     Linear branching - 2 (22.2)
   Distribution
     Diffuse/scattered - 1 (11.1)
     Regional 1 (5.6) -
     Clustered 15 (83.3) 5 (55.6)
     Linear 2 (11.1) 2 (22.2)
     Segmental - 1 (11.1)
   Numbers
     <10 4 (22.2) 3 (33.3)
     10–20 7 (38.9) 2 (22.2)
     >20 7 (38.9) 4 (44.4)
   Final assessment†
     4A 16 (88.9) 4 (44.4)
     4B 2 (11.1) 2 (22.2)
     4C - 3 (33.3)
*Mean±SD; †Category of Breast Imaging-Reporting and Data System.
mation rate was 16.7% (2/12) on 8-gauge and 46.7% (7/15) on 
11-gauge needles. 
The residual calcifications after VABB in the benign and 
Figure 1. A 45-year-old woman with ductal carcinoma in situ. (A) Magnification view of mediolateral mammography reveals clustered pleomorphic 
calcifications measuring 11 mm at the longest dimension in left upper central breast. Vacuum-assisted breast biopsy was performed with 11-gauge 
needle and the localizing clip was placed. (B) Radiography of the vacuum-assisted breast biopsy specimens revealed calcification and the diagnosis 
was atypical ductal hyperplasia. (C) Mediolateral mammography of the left breast obtained after 1 week shows localizing clip without evidence of re-
sidual calcifications. After surgery, the pathologic diagnosis was ductal carcinoma in situ.
A B C
Table 2. Underestimation rate of atypical ductal hyperplasia with com-
parison of residual pathology on excisional biopsy samples
Excisional biopsy 8 Gauge 11 Gauge Total
Benign 10 8 18
Malignancy 2 7 9
Underestimation rate* 16.7 (2/12) 46.7 (7/15) 33.3 (9/27)
*Percent (number of proven malignancytotal number).
Table 3. Residual calcifications with comparison of residual pathology 
on excisional biopsy of atypical ductal hyperplasia diagnosed with vac-
uum-assisted breast biopsy
Residual microcalcification Benign Malignant Total
Yes (n=17)
   4A* 10 1 11
   4B or C* 1 5 6
No (n=10)
   4A* 6 3 9
   4B or C* 1 0 1
Total 18 9 27
*Category of Breast Imaging-Reporting and Data System.
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Among the patients classified as having BI-RADS category 4A 
lesions, three out of nine patients without residual calcifica-
tions (33.3%) were upgraded, whereas only one out of 11 pa-
tients with residual calcifications (9.1%) was upgraded. Among 
the patients classified with category 4B or 4C lesions, there 
were no upgraded patients without residual calcifications (0/1), 
whereas five out of six patients with residual calcifications 
(83.3%, 5/6) were upgraded.
DISCUSSION
ADH is a disease entity of the proliferative breast lesion 
characterized as a ductal lesion with cytoarchitectural atypia 
beyond the normal range, yet insufficient for a DCIS diagnosis 
[15]. It has been found in approximately 4% to 8% of all breast 
biopsies, which is similar to the 6.7% (35/528) of the VABB bi-
opsies in our study [12,14,15]. Several attempts have been 
made to identify mammographic characteristics that could 
differentiate malignant from benign cases in diagnosing ADH 
on VABB, but none have been established yet [13,14,16]. 
The 14-gauge CNB is an accurate and easy method to diag-
nose breast pathology, but its application is limited to diagnos-
ing nonmass lesions with microcalcifications only. VABB is the 
preferred method to diagnose ADH, which usually manifests 
as microcalcifications rather than a mass on mammograms 
[17]. McGhan et al. [2] and Arora et al. [8] reported that using 
a larger needle would harvest many more tissue cores, which 
would be necessary for the accurate diagnosis of ADH using 
VABB. In comparison, Nguyen et al. [1] and Lourenco et al. [9] 
reported that there was no statistical significance considering 
the probe size. However, most of these studies were performed 
by using 11-gauge VABB needles [1,14]. In our study, we exam-
ined the underestimation rates of ADH with VABB by com-
paring the needle size and found that the rates were 46.7% for 
11-gauge samples and 16.7% for 8-gauge samples. As has been 
reported by others, our findings show that the underestimation 
rate of 8-gauge VABB was much lower than that of 11-gauge 
VABB, although these differences did not reach statistical signi-
ficance. 
Recent studies indicate that the extraction of all calcifica-
tions (not just some), results in lower underestimation rates of 
ADH with VABB, supporting the hypothesis that retrieving a 
larger volume of tissue lowers the underestimation rate for 
ADH [6,7,12,16]. In line with this hypothesis, the diagnosis of 
ADH would be more reliable and subsequent surgery would 
be unnecessary, if all calcifications were extracted after VABB. 
However, the necessity of further surgery is still highly debat-
ed, and it remains controversial [1,8,12-14]. Some authors re-
ported that if microcalcifications that have been removed 
completely via VABB/CNB show ADH, the lesion may be 
considered to be adequately represented with no risk of ADH 
underestimation, and subsequent excision may not be neces-
sary [1,2,12,13,16,18]. Most of these reports were based on the 
results of 11-gauge/14-gauge VABB samples except for one 
study that examined samples via 9-gauge/11-gauge/14-gauge 
VABB. Other authors reported that patients with no residual 
Figure 2. A 55-year-old woman with ductal carcinoma in situ. (A) Magnification view of mediolateral mammography reveals linear distributed linear 
branching calcifications measuring 18 mm at the longest dimension in left upper medial breast. Vacuum-assisted breast biopsy was performed with 
11-gauge needle and the localizing clip was placed. (B) Radiography of the vacuum-assisted breast biopsy specimens revealed calcification and the 
diagnosis was atypical ductal hyperplasia. (C) Mediolateral mammography of the left breast obtained after 1 week shows localizing clip with remaining 
calcifications. After surgery, the pathologic diagnosis was ductal carcinoma in situ.
A B C
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calcifications on post-VABB mammograms still require sub-
sequent surgery owing to the possibility of underestimation 
[5,8,14]. These studies were conducted by using results found 
with either an 11-gauge or 8-gauge needle. Most previous 
studies were performed by using 11-gauge or smaller needles 
except for the studies performed by Arora et al. and Nguyen et 
al. [1,5,6,8,12-14,16,18]. Our data showed that the under-
estimation rate was 30% even though the calcifications were 
completely extracted after VABB, and that underestimation 
was also present in the 8-gauge VABB needle group (n= 1). 
Moreover, in category 4A lesions, the group with complete ex-
traction of microcalcifications (33.3%) showed a higher up-
grade rate than that with incomplete extraction (9.1%) after 
VABB; in category 4B and 4C lesions, there were no upgraded 
cases with complete extraction. It is worth noting, however, 
that the sample size was too small to evaluate statistical signifi-
cance between complete extraction of microcalcifications and 
BI-RADS category. A larger sample size would be needed for 
future studies assessing this correlation.
This study has several limitations. First, it was a retrospective 
study and patients underwent mammography-guided VABB 
with subsequent surgery because of an ADH diagnosis. There-
fore, a selection bias might exist. Moreover, eight ADH patients 
who did not undergo additional surgery and who were exclud-
ed from this study were classified as ‘category 4A,’ which could 
further influence the selection bias. Second, as the samples we 
collected were only from patients with ADH on VABB, we had 
a small sample size (27 patients), which is not sufficient to pro-
vide an overall picture.
In conclusion, the underestimation rate of ADH was 33.3% 
on VABB. There was no statistically significant difference based 
on the needle size. Even if all microcalcifications were com-
pletely extracted via VABB, the underestimation rate of ADH 
was 30%. Therefore, subsequent excision should be recom-
mended regardless of the presence of residual microcalcifica-
tions.
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